Both of these ASX mining companies have been downgraded by the brokers that cover them, yet their price targets remain well above their current trading levels.

Let’s see what the brokers are saying about them.

Meeka Metals Ltd (ASX: MEK)

This company has just completed a $40 million capital raise at 10 cents per share, with the money to be used to fund its next phase of growth.

More specifically, the money will be used to fund the company’s recent Mt Holland project acquisition, the development of its new Turnberry underground mine which will start in October, additional growth drilling and to strengthen working capital.

Meeka generated $160.8 million in revenue in FY26 and made a net profit of $51.3 million.

Broker Morgans said the company’s recent guidance of 7000-7500 ounces of gold recovered in the September quarter was below their estimate of 9800 ounces.

They added:

We maintain our BUY recommendation on MEK with a revised price target of 17 cents per share. MEK is transitioning to a two-mine underground operation, with Turnberry underground (first ore Jan-27) adding a second ore source to Andy Well. While the September quarter miss has tempered near-term expectations, the Turnberry ramp-up, ore sorter performance and drilling at depth are catalysts that could rebuild confidence and narrow MEK’s discount to net asset value.

Morgans’ price target is 87% higher than the current share price of 9.1 cents (at the time of writing).

American Rare Earths Ltd (ASX: ARR)

This company recently updated the scoping study for its Cowboy State mining project, which estimated an after-tax net present value of US$1.07 billion and a production rate of 2500 tonnes per year of neodymium and praseodymium (NdPr) oxide.

The mine is now expected to run for 26 years, up from 20, and cost US$900 million to bring into production.

American Rare Earths Chief Executive Officer Mark Wall said:

Our ambition is to turn Halleck Creek’s resource scale into a long term source of rare earth materials for American industry. This study gives investors a clearer view of the first development phase and the work that is moving it forward. We are now evaluating a mine with 50% greater processing capacity, 36% more annual NdPr oxide production and a longer operating life than the 2025 base case. That is a substantial platform from which to advance the project.

Bell Potter analysts said in their research note on the company that Halleck Creek remains one of the largest rare earth resources in the US.

The broker has a 55 cent price target on the company, which sits well above the current price of 36 cents (at the time of writing).

If achieved, this would represent a 52% return.

The post 2 ASX mining companies tipped to jump 52% and 87% appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Tuesday
• A rare buying opportunity in 1 of Australia’s top shares?
• How much must I invest in Telstra shares to earn a $1,000 passive income in 2027?
• This ASX health technology company could more than double in value: Broker
• How much could the big 4 banks’ share prices fall?

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

I think that Telstra Group Ltd (ASX: TLS) is one of the most appealing ASX blue-chip shares to consider for passive income because of how much the business is paying.

As a very profitable business, Telstra is rewarding investors with large and growing dividend payments.

Dividends aren’t guaranteed, of course, but in a defensive industry like telecommunications, the payouts are more reliable and resilient than in many other sectors, in my view.

Let’s get into how Telstra could deliver $1,000 of annual passive income in 2027.

Telstra dividend projection

The business delivered strong dividend growth in FY26, increasing its annual dividend per share by 10.5% to 21 cents. Not many ASX blue-chip shares grew their payout by that much in FY26.

Things could get even better for shareholders in the 2027 financial year, and that’s what I think investors should focus on for the current financial year. FY26 is now the past.

According to CommSec, analysts are now projecting the annual dividend per share could grow to 22 cents per share. That would be a grossed-up dividend yield of 6.5%, including franking credits, at the time of writing.

Not many ASX blue-chip shares are offering that sort of potential yield, with further growth projected to come in the following financial year (FY28).

What would it take for $1,000 of passive income in 2027?

The amount required for $1,000 of annual dividends in FY27 depends on whether franking credits are included in the income.

With a passive income projection of 22 cents per share in the 2027 financial year, it would require 4,546 Telstra shares to generate that much dividend cash.

If we include franking credits as part of the dividend income, it would take 3,182 Telstra shares to reach the $1,000 grossed-up dividend income goal.

Is this a good time to invest in Telstra shares?

Analysts are largely positive or neutral on the business right now. According to CommSec’s collation of expert ratings, there are currently seven buys, eight holds, and one sell rating on the business.

Telstra expects both of its measures of operating profit (underlying EBITDAaL and cash EBIT) to rise in the single digits in FY27. Underlying EBITDAaL could come between $8.5 billion and $8.8 billion, while cash EBIT could reach between $4.75 billion and $4.95 billion.

While faster growth would be preferred, the company continues to demonstrate its ability to grow earnings, whether that’s during good times or not.

Australia’s ongoing digitalisation and growing population are both demand drivers for connection to the company’s mobile network or its fibre network, which can help earnings and the dividend in the coming year.

The post How much must I invest in Telstra shares to earn a $1,000 passive income in 2027? appeared first on The Motley Fool Australia.

More reading

• Telstra vs Woodside: Which ASX dividend stock comes out on top?
• A leading fund just bought these top ASX 200 shares
• How much superannuation do I need to earn $56,000 per year in passive income?
• Buy, hold, sell: Deep Yellow, SGH, Telstra shares
• With $2.4 billion in FY26 profits, are Telstra shares a good buy today?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has positions in and has recommended Telstra Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

ASX health technology company Blinklab Ltd (ASX: BB1) is entering an interesting phase, broker Morgans believes, with several share price catalysts soon to emerge.

New technology opening up a large market

Blinklab produces smartphone software to diagnose conditions such as autism and ADHD. Morgans noted that readouts from four exploratory programs are soon to be published.

Blinklab has almost fully recruited participants for a pivotal study for autism, with Morgans saying this should be completed by the end of the year, with submission to the US Food and Drug Administration expected in the first quarter of calendar 2027.

Morgans added:

BB1’s technology has broad applications across additional indications (adult autism, dementia detection, ketamine-based pharma intervention) and preliminary data is expected to read out over the next 12 months adding to the cadence of news flow. Recently, BB1’s European ADHD study delivered positive results. A US pilot is due to start in 2QCY27, ahead of a pivotal study mirroring the autism path. We agree with management that this presents a significantly larger commercial opportunity than autism spectrum disorder.

The company also recently announced a major appointment, with Dr Raphael Bernier joining the board.

Dr Bernier was the former clinical lead for mental health at Apple Health. The company said he brought first-hand experience translating clinical science into digital products at a global scale.

Blinklab said at the time:

Dr Bernier brings a rare combination of clinical practice, internationally recognised research leadership and commercial product-development experience. His appointment is intended to deepen the Board’s expertise as BlinkLab progresses its pivotal U.S. FDA 510(k) program for BlinkLab Dx1 and prepares for clinical adoption and commercialisation in the United States, subject to regulatory clearance. Dr Bernier recently retired from Apple Health, where he led the clinical development of the Mental Wellbeing app for iPhone, iPad and Apple Watch. He also conducted early-stage research across released and unreleased products in the Apple ecosystem and supported the rollout of additional products relating to child development and cognitive accessibility.

Morgans said there were significant market opportunities in the diagnosis of autism and ADHD, and Blinklab also had the opportunity to expand into other conditions.

Shares looking cheap

The broker has a 12-month price target of $1.76 on Blinklab shares compared to 66 cents currently.

If achieved, this would be a 166% return. The shares are well down from their 12-month high of $1.10.

Blinklab is valued at $114.6 million.

The post This ASX health technology company could more than double in value: Broker appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Monday
• Tech shares shine while ASX 200 plunges to 4-month low
• Here are the top 10 ASX 200 shares today
• 5 things to watch on the ASX 200 on Friday
• Here are the top 10 ASX 200 shares today

Motley Fool contributor Cameron England has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Apple. The Motley Fool Australia has recommended Apple. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.